THE PRODIGY-5 MICRONUTRIENT FORMULA FOR GENERAL HEALTH: Vitamin A • Vitamin C • Vitamin D • Vitamin E • Vitamin K • Vitamin B6 • Vitamin B12 • Folate • B1 (Thiamin) • B2 (Riboflavin) • B3 (Niacin) 

MICRONUTRIENT FORMULA FOR EYE HEALTH: Lutein • Zeaxanthin • Copper • Zinc 


Vitamin E

From Wikipedia, the free encyclopedia
Vitamin E
Drug class
Tocopherol, alpha-.svg
The α-tocopherol form of vitamin E
Class identifiers
Use Vitamin E deficiencyantioxidant
ATC code A11H
Biological target Reactive oxygen species
Clinical data MedFacts Natural Products
External links
MeSH D014810

Vitamin E refers to a group of compounds that include both tocopherols and tocotrienols.[1][2] Of the many different forms of vitamin E, γ-tocopherol is the most common form found in the North American diet.[3] γ-Tocopherol can be found in corn oil, soybean oil, margarine, and dressings.[4][5] α-tocopherol, the most biologically active form of vitamin E, is the second-most common form of vitamin E in the diet. This variant can be found most abundantly in wheat germ oil, sunflower, and safflower oils.[5][6] As a fat-soluble antioxidant, it interrupts the propagation of reactive oxygen species that spread through biological membranes or through a fat when its lipid content undergoes oxidation by reacting with more-reactive lipid radicals to form more stable products.[7][8][9][10] Regular consumption of more than 1,000 mg (1,500 IU) of tocopherols per day[1] may be expected to cause hypervitaminosis E, with an associated risk of vitamin K deficiency and consequently of bleeding problems.


The nutritional content of vitamin E is defined by α-tocopherol activity. The molecules that contribute α-tocopherol activity are four tocopherols and four tocotrienols, identified by the prefixes alpha- (α-), beta- (β-), gamma- (γ-), and delta- (δ-).[11] Natural tocopherols occur in the RRR-configuration only. The synthetic form contains eight different stereoisomers and is called 'all-rac'-α-tocopherol.[12] Water-soluble forms such as d-alpha-tocopheryl succinate are used as food additive.[citation needed]


Sample of α-tocopherol, one of the various forms of vitamin E

alpha-Tocopherol is an important lipid-soluble antioxidant. It performs its functions as antioxidant in the glutathione peroxidase pathway,[13] and it protects cell membranes from oxidation by reacting with lipid radicals produced in the lipid peroxidation chain reaction.[9][14] This removes the free radicalintermediates and prevents the oxidation reaction from continuing. The oxidized α-tocopheroxyl radicals produced in this process may be recycled back to the active reduced form through reductionby other antioxidants, such as ascorbateretinol or ubiquinol.[15] Other forms of vitamin E have their own unique properties; for example, γ-tocopherol is a nucleophile that can react with electrophilicmutagens.[16]


Compared with tocopherols, tocotrienols are sparsely studied.[17][18]


Vitamin E has many biological functions, including its role as a fat-soluble antioxidant.[1]

  • As an antioxidant, vitamin E acts as a peroxyl radical scavenger, disabling the production of damaging free radicals in tissues, by reacting with them to form a tocopheryl radical, which will then be reduced by a hydrogen donor (such as vitamin C) and thus return to its reduced state.[19] As it is fat-soluble, it is incorporated into cell membranes, which protects them from oxidative damage. Vitamin E has also found use as a commercial antioxidant in ultra high molecular weight polyethylene (UHMWPE) used in hip and knee implants to replace faulty joints, to help resist oxidation.[20]
  • As an enzymatic activity regulator, for instance, protein kinase C (PKC), which plays a role in smooth muscle growth, can be inhibited by α-tocopherol. α-Tocopherol has a stimulatory effect on the dephosphorylation enzyme, protein phosphatase 2A, which in turn, cleaves phosphate groups from PKC, leading to its deactivation, bringing the smooth muscle growth to a halt.[21]
  • Vitamin E also has an effect on gene expressionMacrophages rich in cholesterol are found in the atherogenetic tissue. Scavenger receptor CD36 is a class B scavenger receptor found to be up-regulated by oxidized low density lipoprotein (LDL) and binds it.[22] Treatment with α-tocopherol was found to downregulate the expression of the CD36 scavenger receptor gene and the scavenger receptor class A (SR-A)[22] and modulates expression of the connective tissue growth factor (CTGF).[23][24] The CTGF gene, when expressed, is responsible for the repair of wounds and regeneration of the extracellular tissue lost or damaged during atherosclerosis.[24]
  • Vitamin E also plays a role in eye and neurological functions,[1][25] and inhibition of platelet coagulation.[26][27][28]
  • Vitamin E also protects lipids and prevents the oxidation of polyunsaturated fatty acids.[29]

So far, most human supplementation studies about vitamin E have used only α-tocopherol. This can affect levels of other forms of vitamin E, e.g. reducing serum γ- and δ-tocopherol concentrations. Moreover, a 2007 clinical study involving α-tocopherol concluded supplementation did not reduce the risk of major cardiovascular events in middle-aged and older men.[30]


Main article: Vitamin E deficiency

Vitamin E deficiency can cause:


Vitamin E supplementation has not been shown to have significant benefit for people who are healthy, and appears to be harmful.[33][34] It does not improve blood sugar control in an unselected group of people with diabetes mellitus[35] or decrease the risk of stroke.[36] Daily supplementation of vitamin E does not decrease the risk of prostate cancer, and may increase it.[1][37] Studies on its role in age-related macular degeneration are ongoing, though if it is of a combination of dietary antioxidants used to treat the condition it may increase the risk.[38] Routine supplementation with vitamin E during pregnancy has been shown to offer no benefit to the mother or the child. Vitamin E has been reported to cause more side effects, such as abdominal pain in pregnant women, and also the increased risk of having early rupture of membranes at term.[39]

Vitamin E, along with β-carotene and vitamin C, has no protective effect on reducing the risk of cataract, cataract extraction, progression of cataract, and slowing the loss of visual acuity.[40]

Clinical applications

Vitamin E and its analogs are used to prevent and repair cell and tissue damage during radiation therapy. Vitamin E with adjuvant Evening Primrose Oil may reduce breast pain.[41]

The use of vitamin E in the treatment of some cancers is beneficial. Vitamin E and its derivatives promote tumor susceptibility of ionizing radiation during cancer treatment.[42]


Main article: Hypervitaminosis E

The LD50, or the toxic dose required to kill 50% of group of rats and mice, respectively is 4000 mg of VitaminE E/kg of rat and 4000 mg of Vitamin E/kg of mouse.[43] Comparatively speaking, and at lethal doses, Vitamin E is less toxic than table salt and acetaminophen and it is more toxic than ethanol and Vitamin C. Vitamin E can act as an anticoagulant, increasing the risk of bleeding problems. As a result, many agencies have set a tolerable upper intake levels (UL) at 1,000 mg (1,500 IU) per day.[1] In combination with certain other drugs such as aspirin, hypervitaminosis E can be life-threatening.[citation needed] Hypervitaminosis E may also counteract vitamin K, leading to a vitamin K deficiency.[citation needed]

Dietary sources

mg/(100 g)
[note 1]
Some foods with vitamin E content[8]
low high
150 Wheat germ oil
44 Canola/rapeseed oil
41 Sunflower oil
95 Almond oil
34 Safflower oil
26 Almonds
19 Wheat germ
15 Palm oil[44]
15 Hazelnuts
14 Olive oil
12.2 Common purslane[45]
8.33 Peanut
1.5 3.4 High-value green, leafy vegetables: spinachturnipbeet greens, collard greens, and dandelion greens[note 2]
2.32 Butter
2 Avocados[46]
1.8 Cocoa butter
1.4 Sesame oil[47]
1.1 1.5 Asparagus[note 3]
1.5 Kiwifruit (green)
0.90 Cashew nuts
0.78 1.5 Broccoli[note 4]
0.8 1 Pumpkin[note 5]
0.26 0.94 Sweet potato[note 6]
0.9 Mangoes
0.7 Walnuts
0.54 0.56 Tomatoes[note 7]
0.36 0.44 Rockfish[note 8]
0.3 Papayas
0.25 Tahini
0.13 0.22 Low-value green, leafy vegetables: lettuce[note 9]

Dietary Reference Intake

The Food and Nutrition Board (FNB) of the U.S. Institute of Medicine updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for vitamin E in 2000. The current EAR for vitamin E for women and men ages 14 and up is 12 mg/day. The RDA is 15 mg/day. RDAs are higher than EARs so as to identify amounts that will cover people with higher than average requirements. RDA for pregnancy equals 15 mg/day. RDA for lactation equals 19 mg/day. For infants up to 12 months the Adequate Intake (AI) is 4–5 mg/day and for children ages 1–13 years the RDA increases with age from 6 to 11 mg/day. The FNB also sets Tolerable Upper Intake Levels (ULs) for vitamins and minerals when evidence is sufficient. In the case of vitamin E the UL is 1,000 mg/day.[48] Collectively the EARs, RDAs and ULs are referred to as Dietary Reference Intakes. The European Food Safety Authority reviewed the same safety question and set a UL at 300 mg/day.[49]

For U.S. food and dietary supplement labeling purposes the amount in a serving is expressed as a percent of Daily Value (%DV). For vitamin E labeling purposes 100% of the Daily Value was 30 mg, but as of May 2016 it has been revised to 15 mg. A table of the pre-change adult Daily Values is provided at Reference Daily Intake. Food and supplement companies have until July 28, 2018 to comply with the change.


Vitamin E was discovered in 1922 by Herbert McLean Evans and Katharine Scott Bishop[50] and first isolated in a pure form by Gladys Anderson Emersonin 1935 at the University of California, Berkeley.[51] Erhard Fernholz elucidated its structure in 1938 and shortly afterwards the same year, Paul Karrer and his team first synthesized it.[52]

The first use for vitamin E as a therapeutic agent was conducted in 1938 by Widenbauer, who used wheat germ oil supplement on 17 premature newborn infants suffering from growth failure. Eleven of the original 17 patients recovered and were able to resume normal growth rates.[53]

In 1945, Drs. Evan V. Shute and Wilfred E. Shute, siblings from Ontario, Canada, published the first monograph arguing that megadoses of vitamin E can slow down and even reverse the development of atherosclerosis.[54] Peer-reviewed publications soon followed.[55][56] The same research team also demonstrated, in 1946, that α-tocopherol improved impaired capillary permeability and low platelet counts in experimental and clinical thrombocytopenicpurpura.[57]

Later, in 1948, while conducting experiments on alloxan effects on rats, Gyorge and Rose noted rats receiving tocopherol supplements suffered from less hemolysis than those that did not receive tocopherol.[58] In 1949, Gerloczy administered all-rac-α-tocopheryl acetate to prevent and cure edema.[59][60]Methods of administration used were both oral, that showed positive response, and intramuscular, which did not show a response.[53] This early investigative work on the benefits of vitamin E supplementation was the gateway to curing the vitamin E deficiency-caused hemolytic anemia described during the 1960s. Since then, supplementation of infant formulas with vitamin E has eradicated this vitamin’s deficiency as a cause for hemolytic anemia.[53]

Vitamin E supplementation and cardiovascular disease

Vitamin E and atherosclerosis

Atherosclerosis is a disease condition refer to the buildup of plaque, which is a substance containing lipid and cholesterol (mainly the low-density lipoprotein or LDL cholesterol) on the inner layer of the arterial lumen.[61] With the existing plaque, instead of being smooth and elastic, the layers become thickened and irregular and the lumen of the artery become narrower. This vessel-narrowing effect lead to a reduction of blood circulation and can lead to or worsen the condition of hypertension.[62]

There are currently multiple theories explaining factors causing and affecting the cholesterol plaque build up within arteries with the most popular theory indicating that the rate of build up is affected by the oxidation of the LDL cholesterol. LDL cholesterol is one of the five major groups of lipoproteins with one of the physiological roles being lipid transportation. A typical LDL particle contain 2,700 fatty acid molecules and half of them are poly-unsaturated fatty acids, which are very oxidation sensitive.[63] Once the oxidation of LDL occur, it will start a series of undesirable effects starting from the increase production of inflammatory cytokines by stimulating the endothelial cells and monocytes, followed by increased production of tissue factors, production of macrophages and monocytes, which eventually lead to the formation of foam cells and accelerated development of atherosclerosis. With the presence of adequate concentration of vitamin E, which is a very potent fat-soluble antioxidant, it can inhibit the oxidation of LDL, and this inhibition contributes protection against the development of atherosclerosis and can stabilize the existing plaque.[63]

Critical evaluation of current related literature

Interpreting the science jargon of the following paragraphs: If human trials are similar enough in design and measurements, a statistical analysis can be conducted on the combined results. This is called a meta-analysis. Controversies arise when different authors disagree on the criteria to use to include or exclude trials. An odds ratio (OR) indicates whether a treatment helped or harmed compared to control. In the first example below, an OR = 0.74 means that the risk of cardiovascular disease was reduced by 26%. An inverse association (the next referenced example) means that the higher the dose, the lower the risk. Odds ratio and relative risk sort of mean the same thing (unless you are a statistician). The paragraphs below are in conflict. The first reports on observing how much vitamin E subjects chose to consume, and their disease outcome. The second describes RCTs, i.e., randomized clinical trials, in which subjects are assigned to get or not get vitamin E, without knowing which group they are in, and tracking results. The conclusion of observational studies is a benefit; the conclusion of RCTs is no benefit. (As indicated by the ORs being close to 1.00, meaning no effect. An OR higher than 1.00 indicates harm.)

According to Asplund (2002)’s [64] meta-analysis, nine cohort studies showed that high intake of tocopherol was associated with a lower risk of CVD events compared with lower intake. The odds ratio (OR) was 0.74 (95% confidential interval (CI): 0.66-0.83). In this study, higher dietary, supplementation and combined vitamin E intake was also associated with lower CHD incidents, as presented in Appendix II. A large cohort study conducted by Rimm et al.[65] in 1993 included 39,919 male health professionals aged between 40 and 75 showed that consumption of more than 60 IU of vitamin E (any form) per day was associated with a lower incidence of CHD compared with less than 7.5 IU/day intake. This study also showed an inverse association between vitamin E supplementation and the incidence of CHD. The relative risk (RR) of at least 100 IU/day for at least two years was 0.63 (95% CI: 0.47-0.84). A European cohort study was conducted by Knekt et al. in 1994. This study also found an inverse relationship between higher vitamin E (any form) intake and lower CHD risk in men and women. In addition, Kushi et al. (1996) discovered an inverse relationship between vitamin E intake and CHD mortality among 34,486 postmenopausal women (RR=0.38, 95% CI: 0.18-0.8; trend: P=0.014).

For the result of RCTs, as mentioned previously, it was controversy. A meta-analysis of 6 RCTs showed no significant association between vitamin E supplementation and CVD mortality; the pooled OR (95% CI) was 1.0 (0.94-1.06) (Vivekananthan et al., 2003). Another meta-analysis of 7 RCTs also showed similar results, with the pooled ORs (95% CI) of cardiovascular events, non-fatal MI, non-fatal stroke, and CVD deaths being 0.98 (0.94-1.03), 1.00 (0.92-1.09), 1.03 (0.93-1.14), and 1.00 (0.94-1.05), respectively [66]


  1. Jump up^  "USDA Nutrient Data Laboratory". In notes 2–11, USDA NDL Release 24 numbers are given as mg/(100 g). Low and high values vary some by raw versus cooked and by variety.
  2. Jump up^  Spinach (2.0 raw, 2.1 cooked), turnip (2.9 raw, 1.9 cooked), beet (1.5 raw, 1.8 cooked), collard (2.3 raw, 0.88 cooked), and dandelion greens (3.4 raw, 2.4 cooked)
  3. Jump up^  1.1 raw, 1.5 cooked
  4. Jump up^  0.78 raw, 1.5 cooked
  5. Jump up^  1. raw, 0.8 cooked
  6. Jump up^  0.26 raw, 0.94 boiled
  7. Jump up^  0.54 raw, 0.56 cooked
  8. Jump up^  0.36 raw, 0.44 cooked
  9. Jump up^  Lettuce (0.18 iceberg, 0.22 green leaf, 0.13 romaine, 0.15 red leaf, 0.18 butterhead)


  1. Jump up to:a b c d e f "Vitamin E — Health Professional Fact Sheet". Office of Dietary Supplements, US National Institutes of Health. 9 May 2016. Retrieved 5 February 2015.
  2. Jump up^  Brigelius-Flohé R, Traber MG; Traber (1999). "Vitamin E: function and metabolism". FASEB J13 (10): 1145–1155. PMID 10385606.
  3. Jump up^  Traber, MG (1998). "The biological activity of vitamin E". The Linus Pauling Institute. Retrieved 6 March 2011.
  4. Jump up^  Bieri JG, Evarts RP; Evarts (1974). "γ-Tocopherol: metabolism, biological activity and significance in human vitamin E nutrition". American Journal of Clinical Nutrition27 (9): 980–986. PMID 4472121.
  5. Jump up to:a b c Brigelius-Flohé R, Traber MG; Traber (1 July 1999). "Vitamin E: function and metabolism". FASEB J13 (10): 1145–55. PMID 10385606.
  6. Jump up^  Reboul E, Richelle M, Perrot E, Desmoulins-Malezet C, Pirisi V, Borel P; Richelle; Perrot; Desmoulins-Malezet; Pirisi; Borel (15 November 2006). "Bioaccessibility of carotenoids and vitamin E from their main dietary sources". Journal of Agricultural and Food Chemistry54 (23): 8749–8755. doi:10.1021/jf061818sPMID 17090117.
  7. Jump up^  Choe, Eunok; Min, David B (October 2009). "Mechanisms of Antioxidants in the Oxidation of Foods"Comprehensive Reviews in Food Science and Food Safety8 (4): 345–358. doi:10.1111/j.1541-4337.2009.00085.x. Retrieved 4 September 2016.
  8. Jump up to:a b c d e f g National Institute of Health (4 May 2009). "Vitamin E fact sheet".
  9. Jump up to:a b Herrera E, Barbas C; Barbas (2001). "Vitamin E: action, metabolism and perspectives". Journal of Physiology and Biochemistry57 (2): 43–56. doi:10.1007/BF03179812PMID 11579997.
  10. Jump up^  Packer L, Weber SU, Rimbach G; Weber; Rimbach (2001). "Molecular aspects of α-tocotrienol antioxidant action and cell signalling"Journal of Nutrition131 (2): 369S–73S. PMID 11160563.
  11. Jump up^  Traber, M.G. "19". In Ross, A. Catherine. Modern Nutrition in Health and Disease (11 ed.). Philadelphia, PA: Lippincott Williams & Wilkins. pp. 293–294. ISBN 9781605474618.
  12. Jump up^  Traber, MG. "Chapter 15: vitamin E". In Bowman BA and Russell RM. Current Knowledge in NutritionI (9 ed.). Washington DC, USA: ILSI. ISBN 978-1-57881-199-1.
  13. Jump up^  Wefers H, Sies H; Sies (1988). "The protection of ascorbate and glutathione against microsomal lipid peroxidation is dependent on Vitamin E". European Journal of Biochemistry174 (2): 353–357. doi:10.1111/j.1432-1033.1988.tb14105.xPMID 3383850.
  14. Jump up to:a b Traber MG, Atkinson J; Atkinson (2007). "Vitamin E, Antioxidant and Nothing More"Free radical biology & medicine43 (1): 4–15. doi:10.1016/j.freeradbiomed.2007.03.024PMC 2040110Freely accessiblePMID 17561088.
  15. Jump up^  Wang X, Quinn PJ; Quinn (1999). "Vitamin E and its function in membranes". Progress in Lipid Research38 (4): 309–36. doi:10.1016/S0163-7827(99)00008-9PMID 10793887.
  16. Jump up^  Brigelius-Flohé R, Traber MG; Traber (1999). "Vit amin E: function and metabolism". FASEB J13 (10): 1145–55. PMID 10385606.
  17. Jump up^  Ahsan, H; Ahad, A; Siddiqui, W. A. (2015). "A review of characterization of tocotrienols from plant oils and foods"Journal of Chemical Biology8 (2): 45–59. doi:10.1007/s12154-014-0127-8PMC 4392014Freely accessiblePMID 25870713.
  18. Jump up^  "Vitamin E". Mayo Clinic. 2016. Retrieved 12 October 2016.
  19. Jump up^  Traber MG, Stevens JF; Stevens (2011). "Free Radical Biology and Medicine – Vitamins C and E: Beneficial effects from a mechanistic perspective"Free Radical Biology and Medicine51 (5): 1000–13. doi:10.1016/j.freeradbiomed.2011.05.017PMC 3156342Freely accessiblePMID 21664268.
  20. Jump up^  UHMWPE Biomaterials Handbook, 2nd Edition, Kurtz ed. (2009)
  21. Jump up^  Schneider C (2005). "Chemistry and biology of vitamin E". Mol Nutr Food Res49 (1): 7–30. doi:10.1002/mnfr.200400049PMID 15580660.
  22. Jump up to:a b Devaraj S, Hugou I, Jialal I; Hugou; Jialal (2001). "-Tocopherol decreases CD36 expression in human monocyte-derived macrophages". J Lipid Res42 (4): 521–527. PMID 11290823.
  23. Jump up^  Azzi A, Stocker A; Stocker (2000). "Vitamin E: non-antioxidant roles". Prog Lipid Res39 (3): 231–255. doi:10.1016/S0163-7827(00)00006-0PMID 10799717.
  24. Jump up to:a b Villacorta L, Graça-Souza AV, Ricciarelli R, Zingg JM, Azzi A; Graça-Souza; Ricciarelli; Zingg; Azzi (2003). "α-Tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-α-mediated downregulation in human smooth muscle cells". Circ. Res92 (1): 104–110. doi:10.1161/01.RES.0000049103.38175.1BPMID 12522127.
  25. Jump up^  Muller DP (2010). "Vitamin E and neurological function. Review". Mol. Nutr. Food Res54 (5): 710–718. doi:10.1002/mnfr.200900460PMID 20183831.
  26. Jump up^  Dowd P, Zheng ZB; Zheng (1995). "On the mechanism of the anticlotting action of vitamin E quinone"Proc Natl Acad Sci U S A92 (18): 8171–8175. Bibcode:1995PNAS...92.8171Ddoi:10.1073/pnas.92.18.8171PMC 41118Freely accessiblePMID 7667263.
  27. Jump up^  Brigelius-Flohé R, Davies KJ; Davies (2007). "Is vitamin E an antioxidant, a regulator of signal transduction and gene expression, or a 'junk' food? Comments on the two accompanying papers: "Molecular mechanism of alpha-tocopherol action" by A. Azzi and "Vitamin E, antioxidant and nothing more" by M. Traber and J. Atkinson". Free radical biology & medicine43 (1): 2–3. doi:10.1016/j.freeradbiomed.2007.05.016PMID 17561087.
  28. Jump up^  Atkinson J, Epand RF, Epand RM; Epand; Epand (2008). "Tocopherols and tocotrienols in membranes: a critical review". Free radical biology & medicine44 (5): 739–64. doi:10.1016/j.freeradbiomed.2007.11.010PMID 18160049.
  29. Jump up to:a b Whitney, Ellie; Sharon Rady Rolfes (2011). Peggy Williams, ed. Understanding Nutrition (Twelfth ed.). California: Wadsworth, Cengage Learning. ISBN 0-538-73465-5.
  30. Jump up^  Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM; Buring; Christen; Kurth; Belanger; MacFadyen; Bubes; Manson; Glynn; Gaziano (2008). "Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Trial"JAMA: the Journal of the American Medical Association300 (18): 2123–33. doi:10.1001/jama.2008.600PMC 2586922Freely accessiblePMID 18997197.
  31. Jump up to:a b c d e Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
  32. Jump up to:a b c d e Kowdley KV, Mason JB, Meydani SN, Cornwall S, Grand RJ; Mason; Meydani; Cornwall; Grand (1992). "Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption". Gastroenterology102 (6): 2139–42. PMID 1587435.
  33. Jump up^  Bjelakovic, G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C (14 March 2012). "Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases". The Cochrane database of systematic reviews (3): CD007176. doi:10.1002/14651858.CD007176.pub2PMID 22419320.
  34. Jump up^  Haber, David (2006). Health promotion and aging: practical applications for health professionals (4th ed.). New York, NY: Springer Pub. p. 280. ISBN 978-0-8261-8463-4.
  35. Jump up^  Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ; Schmitt; Mendiondo; Marcum; Kryscio (July 2011). "Vitamin E and all-cause mortality: a meta-analysis"Current aging science4 (2): 158–70. doi:10.2174/1874609811104020158PMC 4030744Freely accessiblePMID 21235492.
  36. Jump up^  Bin Q, Hu X, Cao Y, Gao F; Hu; Cao; Gao (April 2011). "The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomized controlled trials". Thrombosis and haemostasis105 (4): 579–85. doi:10.1160/TH10-11-0729PMID 21264448.
  37. Jump up^  Haederle, Michael. "Vitamin E Supplements Raise Risk of Prostate Cancer"Health DiscoveryAARP. Retrieved 11 November 2011.
  38. Jump up^  Olson JH, Erie JC, Bakri SJ; Erie; Bakri (May 2011). "Nutritional supplementation and age-related macular degeneration". Seminars in ophthalmology26 (3): 131–6. doi:10.3109/08820538.2011.577131PMID 21609225.
  39. Jump up^  Rumbold, Alice; Ota, Erika; Hori, Hiroyuki; Miyazaki, Celine; Crowther, Caroline A. (2015-09-07). "Vitamin E supplementation in pregnancy". The Cochrane Database of Systematic Reviews (9): CD004069. doi:10.1002/14651858.CD004069.pub3ISSN 1469-493XPMID 26343254.
  40. Jump up^  Mathew MC, Ervin AM, Tao J, Davis RM; Ervin; Tao; Davis (2012). "Routine Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract"Cochrane Database Syst Rev6 (6): CD004567. doi:10.1002/14651858.CD004567.pub2PMC 4410744Freely accessiblePMID 22696344.
  41. Jump up^  "Vitamin E and Evening Primrose Oil for Management of Cyclical Mastaglgia: A Randomized Pilot Tudy" (PDF). Alternative Medicine Review. Retrieved September 19, 2015.
  42. Jump up^  Singh, Pankaj K.; Krishnan, Sunil (2015). "Vitamin E Analogs as Radiation Response Modifiers". Evidence-Based Complementary and Alternative Medicine2015: 1–16. doi:10.1155/2015/741301ISSN 1741-427X.
  43. Jump up^  Material Safety Data Sheet for Vitamin E, accessdate: September 22, 2015
  44. Jump up^  "Wolfram Alpha" External link in |publisher= (help)
  45. Jump up^  Simopoulos AP, Norman HA, Gillaspy JE, Duke JA (1992). "Common purslane: a source of omega-3 fatty acids and antioxidants". J Am Coll Nutr11 (4): 374–82. doi:10.1080/07315724.1992.10718240PMID 1354675.
  46. Jump up^  "09038, Avocados, raw, California"National Nutrient Database for Standard Reference, Release 26. United States Department of Agriculture, Agricultural Research Service. Retrieved 14 August 2014.
  47. Jump up^ USDA List for Vitamin E in Vegetable Oils
  48. Jump up^  Institute of Medicine (2000). "Vitamin E". Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (PDF). Washington, DC: The National Academies Press. pp. 186–283.
  49. Jump up^  Tolerable Upper Intake Levels For Vitamins And Minerals (PDF), European Food Safety Authority, 2006
  50. Jump up^  Evans HM, Bishop KS; Bishop (1922). "On the existence of a hitherto unrecognized dietary factor essential for reproduction". Science56 (1458): 650–651. Bibcode:1922Sci....56..650Edoi:10.1126/science.56.1458.650JSTOR 1647181PMID 17838496.
  51. Jump up^  Oakes, Elizabeth H. (2007). "Emerson, Gladys Anderson". Encyclopedia of World Scientists. p. 211. ISBN 1438118821{{inconsistent citations}}
  52. Jump up^  Subcommittee on Vitamin Tolerance, Committee on Animal Nutrition, National Research Council (1987). "Vitamin E, in Vitamin Tolerance of Animals". National Academy of Sciences. Retrieved 22 December 2013.
  53. Jump up to:a b c Bell EF (1987). "History of vitamin E in infant nutrition". American Journal of Clinical Nutrition46 (1 Suppl): 183–186. PMID 3300257.
  54. Jump up^  Shute, W. E.; Shute, E. V.; et al., Alpha Tocopherol (Vitamin E) in Cardiovascular Disease. Toronto, Ontario, Canada: Ryerson Press, 1945
  55. Jump up^  Vogelsang A, Shute EV; Shute (June 1946). "Effect of vitamin E in coronary heart disease". Nature157 (3997): 772. Bibcode:1946Natur.157..772Vdoi:10.1038/157772b0PMID 21064771.
  56. Jump up^  Shute EV, Vogelsang AB, Skelton FB, Shute WE; Vogelsang (January 1948). "The influence of vitamin E on vascular disease". Surg Gynecol Obstet86 (1): 1–8. PMID 18920873.
  57. Jump up^  Skelton F, Shute E, Skinner HG, Waud RA; Shute; Skinner; Waud (1946). "Antipurpuric Action of A-Tocopherol (Vitamin E)". Science103 (2687): 762. doi:10.1126/science.103.2687.762-bPMID 17836459.
  58. Jump up^  György P, Rose CS; Rose (1948). "Effect of dietary factors on early mortality and hemoglobinuria in rats following administration of alloxan". Science108 (2817): 716–718. Bibcode:1948Sci...108..716Gdoi:10.1126/science.108.2817.716PMID 17752961.
  59. Jump up^  Gerloczy F (1949). "Clinical and pathological role of d, 1-alpha tocopherol in premature infants; studies on the treatment of scleroedema". Ann Paediatr173 (3): 171–86. PMID 18140084.
  60. Jump up^  Brion LP, Bell EF, Raghuveer TS; Bell; Raghuveer (2003). Brion, Luc P, ed. "Vitamin E supplementation for prevention of morbidity and mortality in preterm infants"Cochrane Database Syst Rev (4): CD003665. doi:10.1002/14651858.CD003665PMID 14583988These observations explain why even a small dose of 5 mg of dl-alpha-tocopheryl acetate provided enterally has proven to be more efficient than larger intramuscular doses (30 mg) in treating scleredema (Gerlóczy 1949)
  61. Jump up^  American Heart Association, 2015
  62. Jump up^  Maruyama, K; Iso, H (2014). Overview of the Role of Antioxidant Vitamins as Protection Against Cardiovascular Disease: Implications of Aging. Available from: Aging: Oxidative Stress and Dietary Antioxidants (1 ed.). New York: Elsevier Inc. p. Chapter 21.
  63. Jump up to:a b Simon, E; Gariepy, J; Cogny, A; Moatti, A; Simon, A (2001). "Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima–media thickening in asymptomatic men at risk for cardiovascular disease". Atherosclerosis159 (1): 193–200. doi:10.1016/s0021-9150(01)00493-2PMID 11689221.
  64. Jump up^  Asplund, K (2002). "Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review". Journal of Internal Medicine251 (5): 372–392. doi:10.1046/j.1365-2796.2002.00973.xPMID 11982737.
  65. Jump up^  Rimm, E.B; Stampfer, M.J; Ascherio, A (1993). "Vitamin E consumption and the risk of coronary heart disease in men". New England Journal of Medicine328 (20): 1450–6. doi:10.1056/NEJM199305203282004PMID 8479464.
  66. Jump up^  Eidelman, R.S; Hollar, D; Hebert, P.R; Lamas, G.A; Hennekens, C.H (2004). "Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease". Archives of Internal Medicine164 (14): 1552–6. doi:10.1001/archinte.164.14.1552PMID 15277288.

Further reading

  • Brigelius-Flohé R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A; Kelly; Salonen; Neuzil; Zingg; Azzi (2002). "The European perspective on vitamin E: current knowledge and future research". American Journal of Clinical Nutrition76 (4): 703–16. PMID 12324281.

External links


Az eredeti Powerstrips fejlesztőjének, Dr. Minsoo Kim legújabb tapasz fejlesztésére váltottunk:
Nagyobb hatékonyság, jobb ár, megbízhatóbb szállítás!

We have changed! More efficiency, better price, more reliable delivery!
We've switched to the latest product from the original Powerstrips developer, Dr. Minsoo Kim: BEPIC - ALLEVI8 PRO

Wir haben uns verändert! Mehr Effizienz, besserer Preis, zuverlässigere Lieferung!
Wir haben auf das neueste Produkt des ursprünglichen Entwicklers von Powerstrips, Dr. Minsoo Kim, umgestellt: BEPIC - ALLEVI8 PRO

Мы изменились! Больше эффективности, лучше цена, надежнее доставка!
Мы перешли на новейший продукт от оригинального разработчика Powerstrips, доктора Минсу Кима: BEPIC - ALLEVI8 PRO

Nous avons changé ! Plus d'efficacité, un meilleur prix, une livraison plus fiable !
Nous sommes passés au dernier produit du développeur original de Powerstrips, le Dr Minsoo Kim : BEPIC - ALLEVI8 PRO

Siamo cambiati! Più efficienza, prezzo migliore, consegna più affidabile!
Siamo passati all'ultimo prodotto dello sviluppatore originale di Powerstrips, il Dr. Minsoo Kim: BEPIC - ALLEVI8 PRO

> PDF <